Your browser doesn't support javascript.
loading
Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
Maokola, Werner; Ngowi, Bernard; Lawson, Lovetti; Robert, Masanja; Mahande, Michael; Todd, Jim; Msuya, Sia.
Affiliation
  • Maokola W; Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania; Institute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania. Electronic address: drwernerm@yahoo.com.
  • Ngowi B; Mbeya University College of Health Sciences, Tanzania.
  • Lawson L; Zankli Medical Center, Abuja, Nigeria.
  • Robert M; Institute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
  • Mahande M; Institute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
  • Todd J; National Institute of Medical Research Mwanza, Tanzania; London School of Hygiene and Tropical Medicine, United Kingdom.
  • Msuya S; Institute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
Int J Infect Dis ; 103: 562-567, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33276111
ABSTRACT

BACKGROUND:

Isoniazid Preventive Therapy (IPT) is a proven public health tool to reduce Tuberculosis (TB) among people living with HIV. However, its implementation in most countries is suboptimal. This retrospective study was conducted to determine the coverage and factors associated with IPT initiation to inform program scale up and improve quality of service in Tanzania and elsewhere.

METHODS:

Retrospective cohort study design involving HIV clinics in Dar es Salaam, Iringa and Njombe regions from January 2012 to December 2016.

RESULTS:

A total of 171,743 PLHIV were in the cohort from 2012 to 2016. Of these, 166,709 were involved in the analysis. Of those analyzed, 23,970 (14.38%) were ever initiated on IPT. Female sex (aOR = 1.72, 95% CI 1.13, P < 0.001), obesity (aOR = 1.29, 95% CI1.20-1.39, P < 0.001), WHO clinical stage II (aOR = 1.48, 95% CI 1.42-1.55, P < 0.001), enrolment in hospitals (aOR = 1.98, 95% CI 1.89-2.06, P < 0.001), enrolment in Njombe region (aOR = 1.25 95% CI 1.18-1.33, P < 0.001) and enrolment in public health facilities (aOR = 1.93 95% CI 1.82-2.04, P < 0.001) were associated with increased IPT uptake. Being on ART (aOR = 0.67, 95% CI 0.65-0.70, P < 0.001) and severe nutritional status (aOR = 0.72, 95% CI 0.60-0.88, P < 0.001) were associated with decreased IPT initiation.

CONCLUSIONS:

Our study documented low IPT initiation in the study area as well as documented factors which enable IPT initiation and those which impair IPT initiation. Strategies are needed to work on barriers and sustain enabling factors to improve IPT coverage.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / HIV Infections / Isoniazid / Antitubercular Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / HIV Infections / Isoniazid / Antitubercular Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Type: Article